サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1774955

血管内ステントの世界市場

Intravascular Stents

出版日
ページ情報
英文 462 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
血管内ステントの世界市場
出版日: 2025年07月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 462 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管内ステントの世界市場は2030年までに408億米ドルに達する見込み

2024年に280億米ドルと推定される血管内ステントの世界市場は、2024～2030年の分析期間においてCAGR 6.5%で成長し、2030年には408億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである薬剤溶出ステントは、CAGR 6.6%を記録し、分析期間終了時には265億米ドルに達すると予測されます。ベアメタルステントセグメントの成長率は、分析期間のCAGRで6.4％と推定されます。

米国市場は76億米ドルと推定、中国はCAGR10.2％で成長予測

米国の血管内ステント市場は2024年に76億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに84億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.3%と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の血管内ステント市場- 主要動向と促進要因のまとめ

なぜ血管内ステントが心血管治療の進化の中心なのか？

血管内ステントは、冠動脈疾患（CAD）や末梢血管障害の管理において、外科的介入に代わる低侵襲性を提供する要となっています。これらの小さなメッシュ状の管状の器具は、血管を支え、血管形成術後の動脈の開存性を維持するために使用されます。心血管系疾患は依然として世界の死因のトップであり、効果的で耐久性のある治療オプションに対する需要が血管内ステント市場の拡大を牽引しています。技術革新、生活習慣病の有病率の増加、末梢血管や神経血管への適応拡大などが市場成長の主な要因となっています。

重要な動向は、ベアメタルステント（BMS）から薬剤溶出ステント（DES）や生体吸収性スキャフォールド（BRS）への移行です。再狭窄を予防する抗増殖薬を放出するDESは、ステント内再狭窄の発生率が低く、長期予後が改善されたため、BMSに取って代わられています。生体吸収性ステントは、まだ採用の初期段階であるが、時間の経過とともに溶解する一時的な足場を提供することで、次世代の血管インターベンション技術を代表するものです。さらに、ステントデリバリーシステム、コーティング技術、個別化されたステントサイジングの進歩により、手技の成功率が向上し、より広範な血管疾患での使用が拡大しています。

材料とデザインにおける革新は、臨床結果をどのように向上させているか？

血管内ステントの進化は、材料科学とデバイス工学の急速な進歩によって推進されています。ステント構造にコバルトクロム合金や白金クロム合金を使用することで、半径方向の強度、画像下での視認性、屈曲性が向上し、曲がりくねった血管の解剖学的構造をナビゲートするのに不可欠なものとなっています。これらの材料はまた、より細い支柱を可能にし、血管の外傷を軽減し、内皮の治癒を促進します。これと並行して、新世代のDESプラットフォームは、薬剤放出後に分解する生体吸収性ポリマーコーティングを特徴としており、パーマネントポリマーに伴う長期的な炎症や血栓形成リスクを最小限に抑えています。

神経血管や末梢血管の市場では、ニチノール（ニッケルチタン合金）製の自己拡張型ステントが、その超弾性特性と血管の動態に適応する能力により、人気を集めています。さらに、血管内超音波（IVUS）や光干渉断層計（OCT）などの画像技術の統合により、ステントの留置精度が向上し、最適な配置と拡張が保証されるようになっています。ナノテクノロジーに基づくコーティングや遺伝子溶出ステントの調査も進行中で、薬物送達効率を改善し、ステント晩期血栓症などの限界に対処することを目指しています。これらの進歩は、低侵襲血管治療で何が可能かを再定義しています。

どのような治療セグメントと使用事例が採用を牽引しているのか？

冠動脈疾患は依然として血管内ステント使用の最大セグメントであり、世界の処置の大部分を占めています。虚血性心疾患の蔓延は、糖尿病、肥満、高血圧の罹患率の上昇と相まって、先進国市場でも新興国市場でも治療件数に拍車をかけています。血管内ステントは、より柔軟でデリバリーしやすいステントプラットフォームにより、分岐部、慢性完全閉塞、長大なびまん性病変などの複雑な病変に使用されることが多くなっています。これらの技術革新により、インターベンショナルカーディオロジストは、以前はステント留置に適さなかった高リスクの患者グループにも治療を拡大することができます。

冠動脈への応用にとどまらず、末梢動脈疾患（PAD）は、特に高齢化した患者層で注目度が高まっている分野です。自己拡張型ステントは大腿膝窩動脈や腸骨動脈で広く使用されており、生体力学的ストレスの大きい血管で長期開存性を提供しています。神経血管用ステントはまた、脳動脈瘤や虚血性脳卒中の治療、特に血栓除去装置との併用において、使用が拡大しています。このように冠動脈、末梢、神経血管の各領域で使用事例が拡大することで、対応可能な市場規模が拡大するだけでなく、さまざまな血管環境に合わせた特殊な設計のステントに対する需要も高まっています。

臨床的、技術的、地域的な側面から市場の成長を後押ししているのは何か？

血管内ステント市場の成長は、臨床需要、技術革新のパイプライン、ヘルスケアインフラの拡大に関連するいくつかの要因によってもたらされます。最も大きな原動力の1つは、世界人口の高齢化と、それに伴う心血管および末梢血管疾患の増加です。このような人口動態の変化は、特に外来患者や外来診療の現場において、ステントのような侵襲性が低く有効性の高い治療ソリューションに対する持続的な需要を生み出しています。同時に、世界のヘルスケア業界はバリューベースケアに移行しており、在院日数を最小限に抑え、合併症発生率を低減し、長期的な転帰を改善する治療法が好まれています。

もう一つの重要な成長要因は、医療機器メーカーによる次世代ステントプラットフォームへの継続的な研究開発投資です。薬剤溶出技術、生体吸収性材料、AIを統合したステント計画ツールに注力することで、競争の激しい市場での差別化が促進されています。さらに、アジア太平洋、ラテンアメリカ、中東における医療アクセスとカテーテル検査室の急速な拡大が、手技件数の増加に寄与しています。診療報酬の改善、有利な臨床ガイドライン、医師のトレーニングプログラムが、これらの地域での採用をさらに後押ししています。こうした臨床的、技術的、構造的促進要因の融合が、世界の血管内ステント市場の持続的で力強い成長の舞台を整えつつあります。

セグメント

タイプ（薬剤溶出、ベアメタル、生体吸収性）、デリバリーモード（自己拡張型、バルーン拡張型）、製品タイプ（冠動脈、末梢、神経血管）、エンドユーザー（病院・心臓センター、外来手術センター、その他）

調査対象企業の例

  • Abbott Laboratories
  • Alvimedica
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard（now part of BD）
  • Cardinal Health（Cordis）
  • Cook Medical
  • Johnson & Johnson
  • Medinol Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OrbusNeich Medical
  • STENTYS SA
  • Terumo Corporation
  • Terumo Interventional Systems

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31677

Global Intravascular Stents Market to Reach US$40.8 Billion by 2030

The global market for Intravascular Stents estimated at US$28.0 Billion in the year 2024, is expected to reach US$40.8 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$26.5 Billion by the end of the analysis period. Growth in the Bare Metal Stents segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 10.2% CAGR

The Intravascular Stents market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.4 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Intravascular Stents Market - Key Trends & Drivers Summarized

Why Are Intravascular Stents Central to the Evolution of Cardiovascular Treatment?

Intravascular stents have become a cornerstone in the management of coronary artery disease (CAD) and peripheral vascular disorders, offering a minimally invasive alternative to surgical interventions. These small mesh-like tubular devices are used to support blood vessels and maintain arterial patency after angioplasty procedures. With cardiovascular diseases remaining the leading cause of death globally, the demand for effective and durable treatment options is driving the expansion of the intravascular stents market. Technological innovation, growing prevalence of lifestyle diseases, and expanded indications in peripheral and neurovascular applications are among the key contributors to market growth.

A significant trend is the transition from bare-metal stents (BMS) to drug-eluting stents (DES) and bioresorbable scaffolds (BRS). DES, which release antiproliferative drugs to prevent restenosis, have largely replaced BMS due to their lower rate of in-stent restenosis and improved long-term outcomes. Bioresorbable stents, although still in early phases of adoption, represent the next generation of vascular intervention technologies by offering temporary scaffolding that dissolves over time. Additionally, advancements in stent delivery systems, coating technologies, and personalized stent sizing are improving procedural success rates and expanding usage across a broader range of vascular conditions.

How Are Innovations in Materials and Design Elevating Clinical Outcomes?

The evolution of intravascular stents is being driven by rapid progress in materials science and device engineering. The use of cobalt-chromium and platinum-chromium alloys in stent construction has enhanced radial strength, visibility under imaging, and flexibility-critical for navigating tortuous vascular anatomies. These materials also allow thinner struts, which reduce vessel trauma and promote faster endothelial healing. In parallel, new-generation DES platforms feature bioabsorbable polymer coatings that degrade after drug release, minimizing long-term inflammation and thrombogenic risk associated with permanent polymers.

In neurovascular and peripheral vascular markets, self-expanding stents made of nitinol (nickel-titanium alloy) are gaining traction due to their superelastic properties and ability to adapt to vessel dynamics. Moreover, the integration of imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) is enhancing stent placement accuracy, ensuring optimal apposition and expansion. Research into nanotechnology-based coatings and gene-eluting stents is also underway, aiming to improve drug delivery efficiency and address limitations like late stent thrombosis. These advances are redefining what’s possible in minimally invasive vascular therapy.

Which Therapeutic Segments and Use Cases Are Driving Adoption?

Coronary artery disease remains the largest segment for intravascular stent use, accounting for the bulk of global procedures. The widespread prevalence of ischemic heart disease, combined with the rising incidence of diabetes, obesity, and hypertension, is fueling procedural volumes in both developed and emerging markets. Intravascular stents are increasingly being used in complex lesions, such as bifurcations, chronic total occlusions, and long diffuse lesions, thanks to more flexible and deliverable stent platforms. These innovations allow interventional cardiologists to expand treatment to high-risk patient groups that were previously unsuitable for stenting.

Beyond coronary applications, peripheral artery disease (PAD) is a growing area of focus, particularly in aging populations. Self-expanding stents are widely used in the femoropopliteal and iliac arteries, providing long-term patency in vessels subject to high biomechanical stress. Neurovascular stents are also seeing increased deployment in the treatment of cerebral aneurysms and ischemic stroke, especially in conjunction with thrombectomy devices. These expanded use cases across coronary, peripheral, and neurovascular domains are not only increasing total addressable market size but also driving demand for specialized stent designs tailored to different vascular environments.

What’s Fueling the Market Growth Across Clinical, Technological, and Regional Dimensions?

The growth in the intravascular stents market is driven by several factors related to clinical demand, innovation pipelines, and expanding healthcare infrastructure. One of the most significant drivers is the aging global population and the associated rise in cardiovascular and peripheral vascular conditions. This demographic shift is creating sustained demand for less invasive, high-efficacy treatment solutions like stents, particularly in outpatient and ambulatory care settings. Concurrently, the global healthcare industry is moving toward value-based care, favoring interventions that minimize hospital stays, reduce complication rates, and improve long-term outcomes-attributes that intravascular stents are well-positioned to deliver.

Another key growth factor is the ongoing R&D investment by medical device companies in next-generation stent platforms. The focus on drug-eluting technology, bioresorbable materials, and AI-integrated stent planning tools is fostering differentiation in an otherwise competitive market. Additionally, the rapid expansion of healthcare access and catheterization labs in Asia-Pacific, Latin America, and the Middle East is contributing to higher procedural volumes. Reimbursement improvements, favorable clinical guidelines, and physician training programs are further supporting adoption in these regions. The convergence of these clinical, technological, and structural drivers is setting the stage for sustained and robust growth in the global intravascular stents market.

SCOPE OF STUDY:

The report analyzes the Intravascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Drug Eluting Stents, Bare Metal Stents, Bioabsorbable Stents); Delivery Mode (Self-expanding Stents, Balloon-expandable Stents); Product Type (Coronary Stents, Peripheral Stents, Neurovascular Stents); End-Use (Hospitals & Cardiac Centers, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Alvimedica
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard (now part of BD)
  • Cardinal Health (Cordis)
  • Cook Medical
  • Johnson & Johnson
  • Medinol Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • OrbusNeich Medical
  • STENTYS SA
  • Terumo Corporation
  • Terumo Interventional Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cardiovascular Diseases Drives Demand for Intravascular Stents
    • Growing Aging Population With High Risk of Atherosclerosis Expands Stent Implantation Procedures
    • Technological Advancements in Drug-Eluting Stents (DES) Propel Market Differentiation and Outcomes
    • Expansion of Peripheral Artery Disease Treatment Strengthens Demand for Non-Coronary Stent Solutions
    • Rising Preference for Minimally Invasive Angioplasty Procedures Fuels Adoption of Stents
    • Increasing Use of Bioresorbable and Polymer-Free Stents Creates Product Innovation Opportunities
    • Growing Clinical Evidence Supporting Long-Term Outcomes of Newer-Generation Stents Enhances Physician Confidence
    • Development of Hybrid and Dual Therapy Stents Targets Complex Lesion Management
    • Integration of Advanced Imaging (IVUS, OCT) With PCI Procedures Drives Accurate Stent Placement
    • Expansion of Interventional Cardiology Programs in Emerging Markets Unlocks New Patient Segments
    • Surge in Transradial Access Procedures Enhances Demand for Deliverable, Flexible Stent Designs
    • Rising Prevalence of Diabetes and Comorbidities Fuels Need for Advanced Coated and Customized Stents
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravascular Stents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Bare Metal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Bare Metal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Bioabsorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Bioabsorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Bioabsorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Self-expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Self-expanding Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Self-expanding Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • CHINA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Intravascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 101: France Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 137: UK Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Intravascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • INDIA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 212: India Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Intravascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Intravascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Intravascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Intravascular Stents by Type - Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Intravascular Stents by Type - Percentage Breakdown of Value Sales for Drug Eluting Stents, Bare Metal Stents and Bioabsorbable Stents for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Intravascular Stents by End-Use - Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Intravascular Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Others and Hospitals & Cardiac Centers for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Intravascular Stents by Delivery mode - Self-expanding Stents and Balloon-expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Intravascular Stents by Delivery mode - Percentage Breakdown of Value Sales for Self-expanding Stents and Balloon-expandable Stents for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Intravascular Stents by Product Type - Coronary Stents, Peripheral Stents and Neurovascular Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Intravascular Stents by Product Type - Percentage Breakdown of Value Sales for Coronary Stents, Peripheral Stents and Neurovascular Stents for the Years 2015, 2025 & 2030

IV. COMPETITION